Health Care & Life Sciences » Pharmaceuticals | Santen Pharmaceutical Co. Ltd.

Santen Pharmaceutical Co. Ltd.

Santen Pharmaceutical Co. Ltd. ADR
Stock Exchange Other OTC
EPS
$0.71
Market Cap
$6.62 B
Shares Outstanding
399.83 M
Public Float
-
Santen Pharmaceutical Co. Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
407.02 M
Public Float
-
Santen Pharmaceutical Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY78.43
Market Cap
JPY718.09 B
Shares Outstanding
399.83 M
Public Float
337.52 M

Profile

Address
Grand Front Osaka Tower A, 25/F
Osaka Osaka 530
Japan
Employees -
Website http://www.santen.co.jp
Updated 07/08/2019
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products.

Financials

View All
Created with Highcharts 5.0.14Santen Pharmaceutical Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.19 71819 71824 03224 03253 37353 37321 71721 71735 24735 24731 95331 953201420152016201720182019010k20k30k40k50k60k
Created with Highcharts 5.0.14Santen Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.146 260146 260161 831161 831195 291195 291199 096199 096224 942224 942234 026234 026201420152016201720182019050k100k150k200k250k

Akira Kurokawa
Chairman & Chief Executive Officer
Shigeo Taniuchi
President, COO & Representative Director